Home -> Law Blog Directory -> Legal Commentary Blogs -> TalkLeft
OR PHONE (866) 635-1838 for Bankruptcy Help, (866) 635-6190 for Divorce,
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Bankruptcy (866) 635-1838
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Legal Commentary
: TalkLeftBaucus' Base: Big Pharma
By Big Tent Democrat
ADVERTISEMENTS
According to the New York Times, the Pharmaceutical Research and Manufacturers of America will spend $150 million specifically boosting for the health care reform proposal introduced last week by Sen. Max Baucus (D-MT). PhRMA has already spent millions on ads supporting the idea of reform more generically. But now that Baucus has come forward with an industry friendly proposal of his own--one that's significantly less progressive than the other proposals in Congress--PhRMA's throwing it's weight specifically behind his plan.
I'm old enough to remember when candidate Obama railed against special interests and taking lobbyist money. Those were the days . . .
Speaking for me only
Full post as published by TalkLeft on September 14, 2009 (boomark / email).
Lawsuits and Settlements
Medical Records
To Stay out of Pharma's Hands
Hormone Replacement Therapy Lawsuits See Multi-Million Dollar Settlements
HRT Lawsuits Pharma Faces Multi Million Dollar Settlements
Related Searches
Are you the author of this blog? Adding USLaw.com to your Blogroll increases relevance. You qualify to display a USLaw Network badge.
Suggest changes to this blog's description or nominate another for inclusion. Register for updates.

The Max Baucus Health Care Lobbyist Complex
Updated: List of Pharma-Free Experts Published
Baucus: No idea how hell vote on Sotomayor
Sen. Baucus Marks Out Turf on Health Care Reform
Obama wants Senate health bill quickly
C5 "EU Pharma Law and Regulation" Conference, Geneva, November 4-5









